Company intelligence / Profile preview

Aurora Algae

Alameda, California, United Stateszoominfo.com ↗

Ownership: Private
Employees: ~11
Development stage: Preclinical

Overview

Developed proprietary algae strains and large-scale cultivation processes to produce high-value algal products including omega‑3 fatty acids for human health, protein for aquaculture/feed markets, and renewable biofuel components. Demonstrated commercial viability at pilot scale in Australia before being acquired by Reliance Industries in 2015. No clinical results as the company did not develop drugs.

Therapeutic areas: Metabolic DisordersOther
Modalities: ProteinOmega 3 fatty acidsSmall moleculeBiologic
Industry: Non-Drug Biotech

Partnerships

Department of Environment and ConservationOak Investment PartnersGabriel Venture PartnersNoventi Ventures

Beyond the preview

Go deeper on Aurora Algae.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurora Algae.

Explore the full profile